Cancer Genetics, Inc.

A Leader in Drug Discovery Services

Recognized as a leader in drug discovery, preclinical oncology, and immuno-oncology services, Cancer Genetics, Inc. (CGI) is committed to enhancing the development of advanced therapies in precision medicine.

About Our CompanyInvestor Presentation

Latest News

View All News

Tuesday, Oct 20, 2020 1:00 pm EDT

Making Human Organs and
the Path to Replacement

StemoniX CEO Ping Yeh Invited to Speak at the 2020 NJ Association for Biomedical Research 3Rs Webinar Series

Cancer Genetics Participating in Extended Q&A Session

Download Agenda

Established and Trusted

Redefining Our Approach

The trusted brand for delivering products and services that drive efficient and effective drug development and discovery.

Capital Market Access

Capital Market Access

Publicly Traded
Nasdaq Capital Market
Large retail base of shareholders

Global Discovery Services

Global Discovery Services

GLP-compliant Labs
State-of-the-Art Facilities
Secure Data Management
Project Management and Study Design
Diverse and Innovative Customers

Experienced Discovery Alliance

Experienced Discovery Alliance

Bioanalytical Unit
Dedicated Project Management
Study Directors
Quality and Regulatory Team

Meet the CGI Team

Our team of world-class scientists and experienced management is helping empower precision medicine.

View Management Team View Board of Directors
Our Media

Our Media

View our latest press releases, videos, events, and articles in our media collection.

View Media
Excellence in Oncology

Excellence in Oncology

We are focused on preclinical and drug discovery services supporting new oncology therapeutics being developed for patients.

About Discovery Services
Email Alerts

Email Alerts

Stay informed and receive company updates straight to your inbox.

Sign Up Today